Summary of Significant Accounting Policies (Details 5)	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Segment Reporting
Number of operating segments			1
Biotest | Revenue
Collaborative Partner:
Percentages of revenue recognized	9.00%	13.00%	4.00%	3.00%
Lilly | Revenue
Collaborative Partner:
Percentages of revenue recognized	1.00%	15.00%	24.00%	18.00%
Novartis | Revenue
Collaborative Partner:
Percentages of revenue recognized	44.00%	22.00%	44.00%	40.00%
Roche | Revenue
Collaborative Partner:
Percentages of revenue recognized	45.00%	37.00%	19.00%	31.00%